IPO Calendar
Lead Manager
- J P Morgan Chase (515)
- Goldman Sachs (492)
- Morgan Stanley (445)
- Bank of America Merrill Lynch (374)
- Citigroup (236)
- Jefferies (223)
- Credit Suisse (180)
- Barclays (158)
- Cowen and Company (147)
- Deutsche Bank (85)
- Leerink Partners (73)
- Piper Jaffray (70)
- Stifel (67)
- UBS Investment Bank (56)
- Evercore (55)
- RBC Capital (53)
- BMO Capital (52)
- Wells Fargo (48)
- Piper Sandler (43)
- Revere Securities (42)
More +
IPO - Pricing (9)
Cowen and Company
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11 | Voyager Therape | Health-Care | 14 | 5 | COWN | PPRJ | 25.2% | 26.8% | |||
| Oct 8 | CytomX Therapeu | Health-Care | 12 | 6 | BAML | COWN | JEFF | 15% | 7.5% | ||
| Jul 2 | Natera Inc. | Health-Care | 18 | 10 | COWN | MS | PPRJ | 136.6% | 26.3% | ||
| May 14 | Galapagos NV | Health-Care | 42.1 | 6 | COWN | CS | MS | 28.4% | 20.1% | ||
| May 6 | Adaptimmune The | Health-Care | 17 | 11 | BAML | COWN | LRNK | 73.8% | -5.9% | ||
| Apr 30 | Blueprint Medic | Health-Care | 18 | 8 | COWN | GS | 87.9% | 4.8% | |||
| Apr 16 | KemPharm Inc. | Health-Care | 11 | 5 | COWN | RBC | 55.1% | 1.8% | |||
| Feb 13 | Bellerophon The | Health-Care | 12 | 5 | COWN | LRNK | 30.6% | -25.3% | |||
| Jan 30 | Avinger Inc. | Health-Care | 13 | 5 | CNCD | COWN | 1.4% | 4053.8% | |||
*
Lead manager or one of top three managers in an underwriting team.